Inocras Unveils Cancer Foundation Model Trained on Thousands of Whole Genomes
Inocras, a bioinformatics-led company harnessing the power of whole genome data and proprietary analytics to deliver curated insights that advance precision health, today announced a groundbreaking cancer foundation model trained on 2,882 whole genomes across diverse cancer types, marking a major advance in applying AI to precision oncology. Developed in collaboration with the Korea Advanced Institute of Science and Technology (KAIST), the model couples a novel learnable tokenization method with a cancer-aware embedding framework that integrates diverse genomic features into patient-level representations, capturing the molecular patterns that drive tumor biology and clinical outcomes.
Fore Genomics Partners with Inocras to Launch Pediatric Genetic Health Screening and Newborn Sequencing
Today, Fore Genomics, a leader in pediatric genetic health screening, announced a strategic partnership with Inocras, a leading innovator in whole genome sequencing (WGS) and AI-powered genetic analysis technologies, to enhance Fore’s proprietary pediatric and newborn health screening services.
